Simultaneous detection methods for compounds with significantly different properties in the same sample

By continuously connecting different chemical tags in series in the same sample, the problem of simultaneous detection of compounds with large differences in properties is solved, realizing efficient and sensitive compound analysis, simplifying the operation process, and reducing sample volume requirements and equipment investment.

CN115184525BActive Publication Date: 2026-11-17YUJING TECH SHANGHAI CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202211107070.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-13
Publication Date
2026-11-17
Estimated Expiration
2042-09-13

AI Technical Summary

Technical Problem

Existing technologies struggle to detect compounds with vastly different properties simultaneously in the same sample, resulting in lengthy analysis times, high equipment and manpower costs, insufficient detection sensitivity, and difficulty in meeting analytical requirements when sample quantities are limited.

Method used

By continuously connecting different chemical tags in series, the properties of compounds can be altered using these tags, enabling the simultaneous detection of compounds with significantly different properties in the same sample. The same pretreatment method and analytical system are used, including connecting a first-type chemical tag in an aqueous medium and then connecting a second-type tag in an organic or solid medium, followed by mass spectrometry analysis.

Benefits of technology

This technology enables the simultaneous detection of compounds with vastly different properties in the same sample, improving throughput and efficiency, reducing sample volume requirements, simplifying operations, increasing detection sensitivity and report generation speed, and reducing equipment and manpower requirements.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115184525B_ABST
    Figure CN115184525B_ABST
Patent Text Reader

Abstract

This invention discloses a method for the simultaneous detection of compounds with significantly different properties in the same sample. The method includes first inserting a chemical tag a1 into the sample; then, as needed, inserting chemical tags a2-an; and then, through the addition of organic solvents or solid-phase extraction, allowing the target compounds with chemical tags, as well as those that have not reacted with the chemical tags, to enter the organic layer or solid-phase extraction layer; continuing to insert chemical tag b1, and so on, inserting several chemical tags b2-bm that react in the organic or solid-phase medium; each chemical tag reacts sequentially with its corresponding compound in a series manner, partially altering the properties of the target compound. This eliminates the need to divide a sample into several portions and process and measure them separately using different pretreatment methods; instead, simultaneous detection can be achieved using only one pretreatment method and one detection system, greatly improving detection speed and throughput.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of detection technology, and to a method for the simultaneous detection of compounds with significantly different properties in the same sample; specifically, it relates to a method for simultaneously detecting compounds with significantly different properties by continuously connecting different chemical tags in series in the same sample; and particularly, it relates to a method for simultaneously detecting compounds with significantly different properties after being treated with the same pretreatment method by continuously connecting different chemical tags in series. Background Technology

[0002] Liquid chromatography-mass spectrometry (LC-MS) is a relatively new analytical technique with many advantages; however, its operational complexity significantly limits its application in practical work. In specific application scenarios, LC-MS faces numerous practical problems.

[0003] 1. Samples, especially biological samples, often contain target compounds that are not of the same type and may even have significantly different chemical properties. Current methods typically categorize the analyte compounds in the sample into several major classes, classifying them according to their properties and developing different sample pretreatment and analytical methods. This approach usually greatly limits the throughput of sample analysis. Besides requiring more samples, different sample pretreatment procedures and different liquid chromatography-mass spectrometry (LC-MS) methods are usually needed to analyze different types of compounds within a single sample, i.e., different chromatographic columns or systems. Each new pretreatment method requires at least an additional two hours of sample processing and necessitates changing the chromatographic column and system, significantly increasing the time required to analyze a single sample and limiting the number of samples that can be analyzed per day. Moreover, in practical applications, samples don't arrive at the lab all at once, but rather in batches, arriving sporadically. In such cases, if it's impossible to obtain results for all the compounds to be tested in a single experiment, several different methods are needed to analyze all the target compounds in a single sample. Even for a single sample, multiple pretreatment methods are required, which is very time-consuming. Assuming each pretreatment method for a compound takes 2 hours, 3 compounds would require 6 hours. Each time several samples arrive at the lab, a dedicated operator needs to spend 6 hours processing them, causing significant inconvenience for experimental and testing personnel. To address this issue, many labs adopt a method of testing only one compound per day. For example, method 1 is used to test compound A on Monday, method 2 on Tuesday to test compound B, method 3 on Wednesday to test compound C, and so on, to minimize workload. While this approach allows for relatively concentrated sample pretreatment, it results in a single sample analysis report typically taking a week to be issued, significantly impacting report generation efficiency. In addition, because each compound requires a different analytical system, multiple devices are needed for detection. Otherwise, it's necessary to wait for the previous compound to be analyzed before switching to a different system, constantly switching between various analytical systems. This not only reduces efficiency but also easily introduces a large number of operational and systematic errors. To solve this problem, some laboratories have purchased multiple devices and added a large number of staff, using each device to detect only one compound, thus avoiding the problem of switching between different systems on the same device. This involves adding many staff members and assigning different staff to handle sample pretreatment for different compounds. Several devices and many staff members work simultaneously to detect different compounds. While this approach increases the speed of report generation, it requires a large amount of equipment and staff operating at the same time, resulting in poor economic efficiency. It is difficult to implement in every laboratory and is only suitable for large third-party laboratories.

[0004] 2. Because different compounds require specific pretreatment methods and LC-MS systems suitable for their analysis, the automation level of LC-MS is far lower than that of other analytical methods and techniques. Automation requires a similar workflow regardless of the compound being analyzed to facilitate machine design and robotic operation. Vastly different pretreatment methods and constantly changing chromatographic systems hinder the improvement of LC-MS automation, making the design of automated equipment more difficult. This situation results in LC-MS relying heavily on manual operation for extended periods, failing to fully realize its advantages and wasting significant human and material resources on switching between different methods.

[0005] 3. Many compounds in samples, especially biological samples, have significant biological value. However, the challenge in analyzing these compounds is that many are present in very low concentrations, requiring highly sensitive analytical methods. Even sensitive instruments like liquid chromatography-mass spectrometry (LC-MS) cannot always meet these requirements; often, only the highest-performance LC-MS models are sufficient. However, these high-performance models are typically very expensive, costing millions of dollars each, placing a significant financial burden on testing laboratories. As more and more functionally active compounds are discovered in very low concentrations, the demands on detection sensitivity are increasing. Even the most expensive LC-MS instruments on the market struggle to meet these sensitivity requirements.

[0006] 4. Many samples are limited by their characteristics and collection conditions, resulting in a limited sample volume. Therefore, analytical protocols are required to obtain accurate results for the compounds to be analyzed in a single test on a single sample. In many cases, the amount of sample available for analysis is limited, such as small amounts of plasma or serum samples, cerebrospinal fluid, dried blood spots, tissue, sweat, etc., typically with a limited volume, such as 20-50 microliters. Such a small sample volume leaves no extra material for further analysis. However, current methods often require larger sample volumes for secondary or multiple analyses to cover the compounds being analyzed, but this requirement for larger sample volumes can be more harmful to humans or animals. Laboratory animals, due to their smaller body weight and limited bodily fluids (blood, cerebrospinal fluid, tissue, etc.), will suffer health problems from larger sample volumes, leading to physical and psychological issues. These physiological changes, in turn, can result in inaccurate test results. For humans, minimizing the number of samples collected is also very helpful for clinical practice.

[0007] For compounds with relatively similar properties, mass spectrometry detectors can simultaneously analyze multiple compounds in a single analysis. However, in reality, it's common to encounter situations where the properties of the analyte compounds differ significantly, making simultaneous analysis extremely difficult. In practical applications, the properties of analyte compounds vary greatly, for example, differing in polarity, acidity / base properties, charge, active groups, solubility, etc. This makes it difficult to cover different compounds in a single sample pretreatment, the chromatographic system is ill-suited for separating various compounds, and the sensitivity of the mass spectrometry detector falls short of detection requirements. Solving these problems would greatly improve the analytical capabilities of mass spectrometry, significantly increase laboratory efficiency, reduce equipment and personnel costs, and improve the speed and quality of report generation.

[0008] In addition, methods for attaching certain chemical tags to the structure of compounds through derivation have been reported in patents and literature. However, the methods used all involve attaching only one chemical tag in a single experiment. Therefore, the compounds being analyzed must have similar properties and the same chemical groups.

[0009] For example, taking the various typical compounds selected in the embodiments of this invention as examples, there have been reports of detecting dopamine, norepinephrine, and epinephrine individually; or detecting 3-methoxytyrosine, norepinephrine, and epinephrine individually; or detecting aldosterone individually; or detecting cortisol individually. However, these methods all require the detection of these compounds in separate groups. Because the properties of these compounds differ so greatly, there have been no reports of using the same method to detect them in the same sample. For example, the 2018 paper "On-Tissue Chemical Derivatization of Catecholamines Using 4-(N-Methyl)pyridinium Boronic Acid for ToF-SIMS and LDI-ToF Mass Spectrometry Imaging" and the 2012 paper "A new derivatization approach for the rapid and sensitive analysis of brassinosteroids by using ultra-high performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometry" reported the use of boric acid compounds to derive bisphenol hydroxyl groups. This method can be used for the action of phenolic hydroxyl groups, but the reaction requires an anhydrous environment. Biological samples are usually water, such as blood and urine, so the reported methods cannot be used for biological samples. All the reported methods cannot address the requirement that the properties of the analyte compounds vary greatly, necessitating the use of the same pretreatment method and the same analytical system for analysis within a single sample. Summary of the Invention

[0010] The purpose of this invention is to address the shortcomings of the existing technology by providing a method for the simultaneous detection of compounds with significantly different properties by continuously connecting different chemical tags in series within the same sample. This invention solves the problem of detecting different types of compounds by continuously connecting different chemical tags in series, enabling the simultaneous detection of different types of compounds, especially those with significantly different properties, thus resolving the previous requirement of multiple detections for compounds with vastly different properties.

[0011] The objective of this invention is achieved through the following technical solution: This invention provides a method for the simultaneous detection of different types (with significantly different properties) of compounds in the same sample, the method comprising the following steps: S1. After simple processing of the biological sample (such as dilution or protein precipitation), the first chemical tag a1 is added, so that the target compound of class A1 is attached to the chemical tag a1, generating a series of compounds A1+a1, where A1 is the target compound of class 1 that reacts with chemical tag a1; then, as needed, chemical tags a2-an that react in an aqueous medium are added sequentially, generating a series of compounds A2+a2, A3+a2...An+an, where A2, A3...An are compounds of classes 2, 3...n that react with chemical tags a2-an respectively; S2. Using organic solvents or solid-phase extraction agents, extract the compound with chemical tag a1-an and other target compounds B1, B2...Bm that have not reacted with chemical tag a1-an from the aqueous phase and introduce them into an organic or solid medium in preparation for the next stage of chemical tag insertion. S3. In the solution obtained in step S2, chemical tag b1 is added, so that target compound of type B1 is added to chemical tag b1, generating a series of compounds B1+b1; B1 is a type 1 target compound that reacts with chemical tag b1; and so on, using this series reaction method, chemical tags b2-bm that react in organic or solid phase media are added sequentially to generate a series of compounds B2+b2, B3+b2...Bm+bm, where B2, B3...Bm are type 2, 3...m compounds that react with chemical tags b2-bm respectively; different chemical tags do not react with each other; S4. The final reaction solution can be directly analyzed by mass spectrometry or dried, reconstituted, and then analyzed by mass spectrometry.

[0012] The properties of various compounds in biological samples vary greatly, which refers to one or more of the following: large differences in chemical properties, polarity, acidity and base properties, charge properties, chemically active groups, solubility, and content.

[0013] As one embodiment of the present invention, the biological sample is selected from plasma, serum, cerebrospinal fluid, tissue homogenate, dried blood spot, urine, hair, sweat or saliva.

[0014] As one embodiment of the present invention, the organic solvent used in step S2 is selected from one or a mixture of several of the following: tert-butyl methyl ether, methanol, chloroform, dichloromethane, ethyl acetate, acetonitrile, n-hexane, cyclohexane, acetone, butyl acetate, etc.

[0015] The preferred solvent is tert-butyl methyl ether at the 1-position. The amount of tert-butyl methyl ether added is 1:1-5 times the sample volume.

[0016] The preferred solvent 2 is acetonitrile. The amount of acetonitrile added is 1:1-5 times the sample volume.

[0017] In this invention, various compounds are connected to different chemical tags in a series continuous manner. Chemical tags are connected by reacting in an aqueous phase in a biological sample, followed by chemical tags connected by reacting in an organic or solid phase medium.

[0018] As one embodiment of the present invention, the target compound in the biological sample includes one or more types of compounds containing carbonyl groups, compounds containing carboxyl groups, compounds containing amino groups, compounds containing hydroxyl or alcohol groups or phenols, vitamin compounds, lipid compounds, steroids and their derivatives, compounds containing double bonds, and industrial polymers.

[0019] Preferably, the carbonyl-containing compounds include steroid hormone compounds. Preferably, the carboxyl-containing compounds include one or more of fatty acid compounds and organic acid compounds. Preferably, the amine-containing compounds include one or more of amino acids and amino acid metabolites, and organic amine compounds. Preferably, the hydroxyl, alcohol, or phenolic compounds include one or more of carbohydrate compounds, thiols and thiooxides, peptides, and proteins. Preferably, the lipid compounds include one or more of aliphatic compounds, cholesterol, and their derivatives.

[0020] In one embodiment of the present invention, in step S1, the target compounds of class A1…An are highly polar and highly water-soluble compounds. Preferably, the partition coefficient LogP of the octanol / water ratio of the compounds is used for evaluation, and the LogP of these compounds is less than 1.0. The compounds of class B1…Bm are moderately polar and weakly polar compounds. Preferably, their logP is greater than 1.0.

[0021] Target compounds of class A1...An can be introduced into the organic or solid-phase extraction medium by altering their solubility through the addition of corresponding chemical tags a1...an. Compounds with chemical tags b1...bm can also overcome their original weakness of excessive lipid solubility by significantly increasing their water solubility, allowing for reconstitution using a liquid chromatography-mass spectrometry compatible injection solvent.

[0022] As one embodiment of the present invention, the highly polar and water-soluble compound is selected from one or more of amino acids, sugars, highly polar lipids, highly polar carboxylic acids, highly polar amines, and phenolic hydroxyl compounds. Preferably, compounds of class A1...An contain phenolic hydroxyl and amino groups but not carbonyl groups, and compounds of class B1...Bm contain carbonyl groups but not phenolic hydroxyl and amino groups.

[0023] As one embodiment of the present invention, each chemical labeling reagent exhibits high reactivity only towards a specific class of compounds with which it reacts. For example, chemical labeling reagent a1 exhibits strong reactivity towards A1 class compounds.

[0024] As one embodiment of the present invention, each chemically labeled product can be dissolved in a sample dissolution solvent before final liquid chromatography-mass spectrometry (LC-MS) injection.

[0025] In one embodiment of the present invention, the solvent used for sample dissolution before liquid chromatography-mass spectrometry (LC-MS) injection is a mixed solvent with a high proportion of water. The mixed solvent is typically a mixture of water (or a buffered aqueous solution, a weak acid-weak base solution) and methanol (or acetonitrile).

[0026] In one embodiment of the present invention, each chemical labeling reagent has a highly ionizing center. The highly ionizing center is a group that readily gains or loses charge, including one or more of carbonyl, carboxyl, tertiary amine, quaternary amine, primary amine, and benzene ring groups.

[0027] As one embodiment of the present invention, the reaction conditions for each chemically labeled reagent to react with the corresponding class of compounds are compatible.

[0028] In some specific embodiments of the present invention, eight representative typical compounds were selected: dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol. A combination of three sets of chemical tags and a method for connecting the chemical tags in series were invented.

[0029] The first set of chemical labels includes chemical label a1 propionic anhydride and chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. The method includes the following steps: A1. Chemically tagged a1 propionic anhydride is introduced into a biological sample. Propionic anhydride reacts with dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine to generate compounds chemically tagged a1 with dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine. A2. Dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and repinephrine were extracted with tert-butyl methyl ether and chemically tagged a1 compounds with propionic anhydride, as well as aldosterone and cortisol that did not react with chemically tagged a1. All of the above compounds entered the organic layer. A3. Separate the organic layer (tert-butyl methyl ether layer), blow dry, and add chemical tag b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. Chemical tag b1 reacts with aldosterone and cortisol to generate compounds that chemically tag b1 with aldosterone and cortisol. A4. The final solution was dried, reconstituted, and injected into the mass spectrometer for analysis; the reactions of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine were realized, and the resulting dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol were analyzed together.

[0030] In some specific embodiments of the present invention, for representative typical compounds such as dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol, the second set of chemical labels includes chemical label a1 benzoyl chloride and chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. The method includes the following steps: B1. A chemical tag a1 benzoyl chloride is introduced into a biological sample. Benzoyl chloride reacts with dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine to generate compounds chemically tagged with benzoyl chloride a1, which contain dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine. B2. Dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and norepinephrine were extracted using tert-butyl methyl ether and chemically tagged a1 compounds with benzoyl chloride, as well as aldosterone and cortisol that did not react with chemical tag a1; all of the above compounds entered the organic layer. B3. Separate the organic layer (tert-butyl methyl ether layer), dry it, and add chemical tag b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. Chemical tag b1 reacts with aldosterone and cortisol to generate compounds that chemically tag b1 with aldosterone and cortisol. B4. The final solution was dried, reconstituted, and injected into the mass spectrometer for analysis; the reactions of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine were realized, and the resulting dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol were analyzed together.

[0031] In some specific embodiments of the present invention, for representative typical compounds such as dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol, a third set of chemical labels includes chemical label a1 6-aminoquinolinyl-N-hydroxysuccinimide carbamate and chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. The method includes the following steps: C1. A chemically tagged compound a1, 6-aminoquinolinyl-N-hydroxysuccinimide carbamate, is introduced into a biological sample. This compound reacts with dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine to generate compounds chemically tagged with 6-aminoquinolinyl-N-hydroxysuccinimide carbamate, namely, a1-aminoquinolinyl-N-hydroxysuccinimide carbamate. C2. Dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and norepinephrine-linked compounds with 6-aminoquinolinyl-N-hydroxysuccinimide carbamate were extracted using an inert salt and acetonitrile solvent, along with aldosterone and cortisol that were not reacted with chemical tag a1; all of these compounds entered the acetonitrile layer. C3. Separate the organic layer (acetonitrile layer), and insert chemical tag b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. Chemical tag b1 reacts with aldosterone and cortisol to generate compounds that chemically tag b1 with aldosterone and cortisol. C4. The final solution was dried, reconstituted, and injected into the mass spectrometer for analysis; the reactions of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine were realized, and the resulting dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol were analyzed together.

[0032] In step C2, the inert salt reagent includes one or more of sodium chloride, magnesium sulfate, and sodium sulfate.

[0033] As one embodiment of the present invention, the different types of compounds include compounds containing amino and hydroxyl groups (A1) and compounds containing carbonyl groups (B1); in the chemical labeling reagents, chemical labeling reagent a1 is propionic anhydride, and chemical labeling reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. As an example, the compounds containing amino and hydroxyl groups include dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine, and the compounds containing carbonyl groups include aldosterone and cortisol.

[0034] As one embodiment of the present invention, the different types of compounds include compounds containing amino and hydroxyl groups and compounds containing carbonyl groups; chemical labeling reagent a1 is benzoyl chloride, and chemical labeling reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. As examples, the compounds containing amino and hydroxyl groups include dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine; the compounds containing carbonyl groups include aldosterone and cortisol.

[0035] As one embodiment of the present invention, the different types of compounds include compounds containing amine groups and compounds containing carbonyl groups; chemical labeling reagent a1 is 6-aminoquinolinyl-N-hydroxysuccinimide carbamate, and chemical labeling reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride. As examples, the compounds containing amine groups include dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine; the compounds containing carbonyl groups include aldosterone and cortisol.

[0036] Compared with existing technologies, this invention achieves the following objectives by redesigning the analysis process: 1) The method of this invention successfully enables the simultaneous detection of compounds with very different chemical properties, charges, solubilities, chemical groups, and contents in the same sample, even those present in very low concentrations in vivo. It allows for the analysis of all target compounds using the same sample pretreatment method, a single sample, without the need to change the sample pretreatment method or the chromatographic system, greatly improving the throughput and efficiency of detection, solving the problems of throughput and efficiency, and greatly simplifying the operation process.

[0037] 2) The method of the present invention eliminates the difficulty of dividing the sample into multiple parts for sample pretreatment and analysis of compounds with very different properties. It greatly reduces the amount of sample required and only a small amount of sample is needed to achieve accurate analysis of compounds with very different properties. It solves the problem of limited sample volume in many cases, greatly reduces the amount of blood required to complete the detection, and allows accurate analysis of small amounts of biological samples such as cerebrospinal fluid and dried blood spots.

[0038] 3) The method of this invention enables real-time sample detection. Because it is simple to operate, samples sent to the testing laboratory from time to time can be processed and analyzed in real time. There is no need to accumulate samples and then process and analyze them collectively. This greatly improves the speed of sample testing and issuing test reports. You can get the analysis results on the same day instead of waiting a week.

[0039] 4) By adopting the method of the present invention, the polarity of compounds that cannot be effectively extracted by organic solvents, namely highly polar and highly water-soluble compounds, is reduced, so that they can be effectively extracted by organic solvents or solid phase extraction. They can successfully enter the organic layer or solid phase medium from the aqueous layer, thereby achieving purification and enrichment, and solving the problem of difficult purification and enrichment of highly polar and highly water-soluble compounds.

[0040] 5) By using the method of the present invention, through the tandem connection of different chemical tags, compounds with very low content and difficult detection are given groups with high ionization properties, which greatly increases the response on the instrument and obtains higher detection sensitivity. This solves the problem that the detection of compounds is forced to use expensive equipment, and ordinary equipment can also meet the detection requirements.

[0041] 6) The method of the present invention can effectively extract compounds with very different properties in a single sample extraction method, while simultaneously purifying the sample and achieving sample enrichment. This allows for multiple enrichment of the sample, further improving detection sensitivity.

[0042] 7) The method of the present invention simplifies the sample pretreatment process, increases consistency, and facilitates mechanical automation. Attached Figure Description

[0043] Other features, objects, and advantages of the present invention will become more apparent from the following detailed description of non-limiting embodiments with reference to the accompanying drawings: Figure 1 A flowchart illustrating a method for simultaneously detecting compounds with vastly different properties by continuously connecting different chemical tags; Figure 2 This is a diagram showing the effect of successfully sequentially adding chemical labeling reagent a1 (acetic anhydride) and chemical labeling reagent b1 (1-(2-hydrazino-2-oxoethyl)pyridinium chloride) in Example 2; from top to bottom, the substances are cortisol, aldosterone, adrenaline, dopamine, norepinephrine, epinephrine, 3-methoxytyramine, and norepinephrine. Figure 3 This is a diagram showing the effects of sequentially adding chemical labeling reagent a1 (benzoyl chloride) and chemical labeling reagent b1 (1-(2-hydrazino-2-oxoethyl)pyridinium chloride) in Example 2; from top to bottom, they are cortisol, adrenaline, aldosterone, norepinephrine, dopamine, epinephrine, norepinephrine, and 3-methoxytyramine; Figure 4This is a diagram showing the effects of sequentially adding chemical labeling reagent a1 (6-aminoquinolinyl-N-hydroxysuccinimide carbamate) and chemical labeling reagent b1 (1-(2-hydrazino-2-oxyethyl)pyridinium chloride) in Example 3; from top to bottom, the substances are cortisol, aldosterone, norepinephrine, norepinephrine, epinephrine, norepinephrine, 3-methoxytyramine, and dopamine. Figure 5 This is a schematic diagram comparing the traditional method and the method of the present invention; Figure 6 This is a schematic diagram of linear regression of norepinephrine. Figure 7 This is a schematic diagram of linear regression of adrenaline. Figure 8 This is a schematic diagram of linear regression for norepinephrine; Figure 9 This is a schematic diagram of the linear regression of 3-methoxytyramine. Figure 10 This is a schematic diagram of linear regression of dopamine. Figure 11 This is a schematic diagram of linear regression of adrenaline; Figure 12 This is a schematic diagram of linear regression for aldosterone. Figure 13 This is a schematic diagram of linear regression of cortisol. Detailed Implementation

[0044] The present invention will be described in detail below with reference to embodiments. These embodiments will help those skilled in the art to further understand the present invention, but do not limit the invention in any way. It should be noted that those skilled in the art can make several adjustments and improvements without departing from the concept of the present invention. These all fall within the protection scope of the present invention. Unless otherwise specified, the methods described in this invention are conventional methods. Unless otherwise specified, the raw materials are all available from publicly available commercial sources.

[0045] This invention achieves the following objectives by redesigning the analytical process: 1) First, by introducing specific chemical tags, the original chemical properties of the highly polar and water-soluble Class I compounds are altered, reducing their polarity and enabling effective extraction by organic solvents or solid-phase extraction, thereby achieving sample purification and enrichment. Simultaneously, the introduction of chemical tags allows compounds with lower concentrations to acquire stronger ionizing groups, resulting in higher detection sensitivity; 2) Introducing specific chemical tags different from the above alters the chemical properties of Class II compounds, increasing the number of detectable ionizing groups, improving detection sensitivity, and making them easier to analyze chromatographically; 3) The sample extraction flow is redesigned. This process enables the effective extraction of compounds with vastly different properties in a single sample extraction method. Simultaneously, the sample is purified, removing impurities and proteins that could affect analysis, and achieving sample enrichment. This allows for multiple-fold enrichment of the sample, further improving detection sensitivity. 4) By cascading different chemical tags and redesigning the sample pretreatment process, it enables the simultaneous detection of compounds with significantly different chemical properties, charges, solubilities, chemical groups, and concentrations, even those present in very low concentrations in vivo. This allows for the analysis of compounds that previously required multiple methods in a single method, without increasing pretreatment time, significantly improving throughput and efficiency. For the detection of multiple components in a single sample, the wait for analysis reports is no longer a week; real-time sample monitoring and reporting are now possible.

[0046] Step 1: Introduce the first chemical tag, namely chemical tag reagent a1, which reacts chemically with the first type of compound A1, attaching the groups on chemical tag a1 to the first type of compound, generating A1+a1. As needed, after introducing chemical tag a1, appropriate aqueous chemical tags can be selected according to the following principle: for different types of compounds A2-An, chemical tags a2-an are introduced sequentially to generate A2+a2, A3+a3…An+an.

[0047] Taking the selection of chemical label a1 as an example, the selection of aqueous chemical label a1 should meet the following conditions: 1) Chemical label reagent a1 needs to have strong reactivity with the first type of compounds, reacting rapidly at room temperature. If heating is required for the reaction to occur, it may affect the analysis of other compounds later, and increased temperature may threaten the stability of other types of compounds. 2) Chemical label reagent a1 needs to be soluble in the sample dissolution solvent used before final LC-MS injection. To avoid solvent effects, the sample dissolution solvent before LC-MS injection is usually a mixture of water (or buffer solution, or weak acid / weak base solution) and methanol (or acetonitrile) with a high aqueous phase ratio. To ensure the reaction efficiency of the labeling process, chemical label reagent a1 is used in large excess in this invention. Furthermore, for ease of operation, excess chemical label reagent a1 will not be specifically removed during the entire process; otherwise, the purpose of simplifying the operation would be lost. Therefore, chemical label reagent a1 must be soluble in a solvent with a high aqueous phase ratio; otherwise, it will precipitate in the final dissolution step, increasing the difficulty or steps of the operation. 3) Chemical labeling reagent a1 must not react with other chemical labeling reagents to be used later. Its structure must not contain any groups that can react with other chemical labeling reagents. Otherwise, a large excess of chemical labeling reagent a1 will competitively react with chemical labeling reagents a2, a3...an, b1, b2...bm, etc., so that the compounds in the sample can no longer react with chemical labeling reagents a2, a3...an, b1, b2...bm, and lose the labeling ability of chemical labeling reagents a2, a3...an, b1, b2...bm. 4) Class I compounds typically have strong water solubility and high polarity, including amino acids, sugars, highly polar lipids, highly polar carboxylic acids, highly polar amines, phenolic hydroxyl compounds, and hydroxyl compounds. Therefore, the chemical tag reagent A1 also needs to be water-soluble to react with the target compound in an aqueous medium. 5) Compounds with chemical tag A1 need to have their original water solubility and high polarity altered by the addition of chemical tag A1. Polarity needs to be reduced, and the solubility in the organic phase or the adsorption capacity of the solid medium needs to be greatly increased to allow them to enter the organic or solid phase during the reaction. 6) Chemical tag A1 needs to have highly ionized centers, such as carbonyl, carboxyl, tertiary amine, quaternary amine, primary amine, benzene ring, and hydroxyl groups that easily gain or lose charge to improve the subsequent detection sensitivity. Step Two: Add a suitable organic solvent or solid-phase extractant to extract the target compound with chemical tag A1-an and the target compound that has not reacted with chemical tag A1-an into the organic solvent or solid-phase extractant.If an organic solvent that directly separates from water, such as tert-butyl methyl ether or n-hexane, is used, no additional steps are required; the organic solvent can be added directly to the labeled biological sample. If a solvent that does not directly separate from water, such as acetonitrile, is chosen as the extraction organic solvent, the labeled biological sample needs to be transferred to a container containing solid inert salt reagents. Using inert salt reagents such as sodium chloride, magnesium sulfate, or sodium sulfate will cause the biological sample solution to separate into two layers, resulting in the separation of the aqueous layer and the acetonitrile layer. This method creates two liquid environments with different properties: an aqueous layer and an organic solvent layer. The purpose of creating two liquid environments with different properties is: 1) The introduction of the chemical tag a1-an usually requires an aqueous phase environment. Through the introduction of the chemical tag a1, the target compounds A1+a1, A2+a2...An+an tagged with a1-an can enter the organic phase. During the introduction of the chemical reagent a1-an, compounds tagged with a1-an can continuously enter the organic layer, while compounds that cannot react with the chemical tag reagent a1-an remain in the aqueous layer, achieving highly characteristic separation. While achieving the purpose of introducing the chemical tag reagent a1-an, further sample processing is also possible. 1) The product continuously entering the organic phase reduces the concentration of A1+a1, A2+a2...An+an in the aqueous phase, promoting a more complete reaction in the aqueous phase and improving reaction efficiency; 2) The chemical tag b1-bm in step three usually requires an organic medium environment. The presence of the aqueous phase will reduce the activity and rate of the b1-bm incorporation reaction. The two phases formed by the organic solvent or solid medium and water allow the compound B1-Bm to be extracted by the organic solvent, preparing for the subsequent incorporation of the chemical tag b1-bm in a high organic phase environment. In addition to using organic solvents to extract the chemically tagged compounds A1+a1, A2+a2...An+an, as well as the compound B1-Bm that has not reacted with the chemical tag a1, solid phase extraction can also be used for extraction, with the same principle as organic solvent extraction.

[0048] Step 3: In an organic solvent or solid-phase extractant containing dissolved tagged products A1+a1, A2+a2…An+an, and untagged target compounds B1, B2…Bm, add a second type of chemical tag, chemical tagging reagent b1. This reagent reacts chemically with target compound B1, attaching groups from chemical tagging reagent b1 to a series of target compounds B1, generating tagged compounds of type B1+b1. As needed, after attaching chemical tag b1, appropriate organic or solid media can be selected according to the following principles for choosing chemical tag b1. Chemical tags b2-bm are sequentially attached to different types of compounds B2-Bm, generating B2+b2, B3+b3…Bm+bm.

[0049] Taking the selection of chemical label b1 as an example, the selection of chemical label b for organic and solid media is explained: The selection of a suitable chemical label reagent b1 needs to meet the following conditions: 1) Chemical label reagent b1 needs to have strong reactivity towards B1 class compounds, enabling rapid reaction, preferably at room temperature. If heating is required for the reaction to occur, it may affect the analysis of other compounds, and increased temperature may threaten the stability of other types of compounds. 2) Chemical label reagent b1 needs to be soluble in the sample dissolution solvent used before final LC-MS injection. Typically, to avoid solvent effects, the sample dissolution solvent before LC-MS injection is a mixture of water (or buffer solution) and methanol (or acetonitrile) with a high proportion of aqueous phase. To ensure the reaction efficiency of the label insertion process, chemical label reagent b1 is used in large excess in this invention. Furthermore, for ease of operation, excess chemical label reagent b1 will not be specifically removed during the entire process; otherwise, the purpose of simplifying the operation would be lost. Therefore, chemical label reagent b1 must be soluble in a solvent with a high proportion of aqueous phase; otherwise, it will precipitate in the final dissolution step, increasing the difficulty of operation or adding steps to the operation. 3) Chemical labeling reagent b1 must not react with any other chemical labeling reagents that have been added previously or will be used next. Its structure must not contain any groups that can react with other chemical labeling reagents. Otherwise, excessive amounts of chemical labeling reagents a1-an and b1-bm will compete for reaction, making the compounds in the sample unable to react with the subsequent chemical labeling reagents b2...bm, thus losing the labeling ability of chemical labeling reagents b2...bm. 4) B1-Bm type compounds usually have moderate or weak polarity, such as lipid-soluble lipids, steroid hormones, lipid-soluble vitamins, steroid compounds, etc. Therefore, chemical tag reagent b1 also needs to be lipid-soluble and can react with target compound B1 in organic or solid media; 5) Compounds with chemical tag b1 need to overcome their original weakness of being too lipid-soluble by adding chemical tag b1, which can greatly increase their water solubility so that they can be reconstituted using a liquid chromatography-mass spectrometry compatible injection solvent; 6) Chemical tag b1 needs to have highly ionized centers, such as carbonyl, carboxyl, tertiary amine, quaternary amine, primary amine, benzene ring, etc., which are easy to gain or lose charge, in order to improve the subsequent detection sensitivity.

[0050] Step 5: After diluting the organic layer, inject it directly or dry it under nitrogen. Dissolve the dried residue with a high-aqueous solvent and inject it into the liquid chromatography-mass spectrometry instrument for analysis.

[0051] See flowchart Figure 1 For specific examples, please refer to the following embodiments: Example 1 The following specific examples, using the determination of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol as examples, further illustrate the present invention. The present invention uses dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol as examples, but is not limited to these specific examples. The two chemical labels mentioned in the examples are applicable to dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol, but the present invention uses chemical labels applicable to dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol as examples, but is not limited to these two chemical labels. This embodiment uses the addition of one chemical tag a1 to the aqueous medium and the connection of one chemical tag b1 to the organic medium as an example, but it is not limited to connecting one or two chemical tags. As needed, more chemical tags a2-an, b2-bm can be connected.

[0052] This invention employs a tandem method to connect two different chemical tags. It selected eight typical compounds (dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol) with significantly different chemical properties, charges, solubilities, chemical groups, and concentrations, but requiring analysis within the same sample. By connecting two different chemical tags in tandem, simultaneous analysis of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol was achieved. In a single sample and experiment, using only one pretreatment method, the same chromatographic column, chromatographic system, and mass spectrometry system, simultaneous analysis of these typical compounds in 100-200 μL of biological sample was completed. Dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol have very different properties, making it very difficult to detect them using the same analytical methods. The main reasons include: 1) Dopamine, norepinephrine, and epinephrine are highly polar and highly water-soluble. 3-methoxytyrosine, norepinephrine, and epinephrine are metabolites of dopamine, norepinephrine, and epinephrine, respectively. Although their polarity is slightly weaker than that of dopamine, norepinephrine, and epinephrine, it is still very polar compared to other compounds. These six compounds have extremely strong polarity and water solubility, making them difficult to dissolve in commonly used organic reagents. The extremely high water solubility of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine makes them confined to the aqueous phase. This characteristic makes it difficult to extract and separate them from impurities in the aqueous phase for purification. Furthermore, because water is difficult to evaporate and remove, it is difficult to enrich the sample. Aldosterone and cortisol are weakly polar, poorly water-soluble and highly lipid-soluble, and the large difference in polarity between the compounds makes it difficult to achieve a balance. The polarity of compounds is commonly evaluated using the octanol / water partition coefficient (LogP). The LogP values ​​of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol are shown in the table below. The smaller the LogP value, the greater the polarity of the compound. As can be seen from the table, the polarity of the above eight typical compounds differs greatly.

[0053] Table 1. Comparison of Log P values ​​for 8 typical compounds in the examples. Therefore, solvents capable of extracting dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine cannot extract aldosterone and cortisol. Conversely, solvents capable of extracting aldosterone and cortisol cannot extract dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine. 2) The charge properties of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine differ significantly from those of aldosterone and cortisol, making it difficult to pretreat them using solid-phase extraction based on these differences in charge properties. Among them, dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine are basic. This property allows weak cation exchange solid-phase extraction columns to adsorb them relatively well, enabling the extraction of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine. However, aldosterone and cortisol are not basic, so the same solid-phase extraction material has no effect on aldosterone and cortisol, and the same solid-phase extraction material cannot be selected. 3) The chemical groups of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine are different from those of aldosterone and cortisol. Dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine contain both amino and phenolic hydroxyl groups, which are nucleophilic. While aldosterone and cortisol also contain hydroxyl groups, their structures differ from those of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine. The hydroxyl groups in dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and epinephrine are phenolic hydroxyl groups, which exhibit strong anionic properties and nucleophilicity. Aldosterone and cortisol, however, do not possess similar properties as their hydroxyl groups are not phenolic hydroxyl groups. Therefore, these compounds do not have the same chemical groups, but each has its own characteristic chemical groups. The structural formulas of the eight typical compounds are shown below. From the structural formulas, it can be further seen that the chemical properties of these compounds are very different, making it very difficult to analyze them using the same sample pretreatment methods, liquid chromatography methods, and mass spectrometry methods. The structural formulas of the eight typical compounds are shown below. 4) The contents of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol vary greatly. The contents of dopamine, norepinephrine, epinephrine, and aldosterone are very low, while the contents of cortisol are very high. Taking cortisol and aldosterone as examples, the contents of the two in biological samples differ by more than 10,000 times.5) Adrenaline and noradrenaline are isomers with the same molecular weight and cannot be distinguished by the difference in molecular weight. They can only be distinguished by chromatographic retention behavior, but their retention behaviors are also very similar. In traditional methods, the separation of adrenaline and noradrenaline is usually a big challenge and requires special chromatographic columns for effective separation. However, such columns are not suitable for the separation of aldosterone and cortisol.

[0054] The structural formulas of eight typical compounds are shown below: adrenaline and noradrenaline Dopamine becomes adrenaline Norepinephrine-3-methoxytyramine Aldosterone cortisol Figure 5 This diagram illustrates a comparison between conventional methods and the method of this invention. Current methods typically analyze these compounds using three different approaches. The first approach is used to analyze dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and rhabdopine. These six compounds contain both amine and hydroxyl groups. Dopamine, norepinephrine, and epinephrine are present in very low concentrations in vivo, are highly polar, and exhibit poor stability, making detection difficult. Among 3-methoxytyrosine, norepinephrine, and rhabdopine, 3-methoxytyrosine is also present in low concentrations in vivo, making detection challenging; in practice, sometimes only norepinephrine and rhabdopine can be detected. The second approach is used to analyze aldosterone. Because aldosterone is present in very low concentrations in healthy organisms, it is difficult to detect and usually requires separate sample pretreatment for enrichment before detection. The third approach is used to detect cortisol.

[0055] This invention takes dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol as examples. By employing the method of this invention, simultaneous analysis of dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol can be achieved. This method uses these eight typical compounds as examples, but is not limited to the analysis of these eight compounds.

[0056] Chemical label a1 Propionic anhydride: Chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride: 1) Connect chemical tag a1, propionic anhydride: Take 200 μL of plasma and place it in a centrifuge tube. Add 20 μL of stable isotope internal standard solution, 20 μL of ammonium bicarbonate buffer solution, and 50 μL of propionic anhydride solution. Mix well at room temperature and let stand for 10 minutes. 2) In a test tube containing chemical label a1, add 1 ml of tert-butyl methyl ether, mix well, and separate the tert-butyl methyl ether layer; I have tried various organic reagents, including tert-butyl methyl ether, methanol, chloroform, dichloromethane, ethyl acetate, and n-hexane. Only tert-butyl methyl ether has the highest extraction efficiency. Some organic solvents have lower extraction efficiency, such as n-hexane, which has an extraction efficiency of less than 1 / 10 of that of tert-butyl methyl ether. Other organic solvents easily form emulsion layers, making separation difficult. 3) Add chemical label b1: Add 5 μL of acetic acid and 10 μL of 1-(2-hydrazino-2-oxoethyl)pyridinium chloride, mix well, and let stand at room temperature for 10 minutes; 4) The solution after the reaction was dried under nitrogen at room temperature, redissolved with 25% methanol solution, and injected into a liquid chromatography-mass spectrometry (LC-MS) instrument for analysis; The reaction equations for the chemical labeling process described above are shown in Equations I1-I6 and II1-II2: (Formula I1, dopamine is attached to chemical tag a1) (Formula I2, adrenaline is attached to chemical tag a1) (Formula I3, norepinephrine is attached to chemical tag a1) (Formula I4, with adrenaline linked to chemical tag a1) (Formula I5, norepinephrine is attached to chemical tag a1) (Formula I 6,3-methoxytyramine is added to chemical tag a1) The above reaction occurs in an aqueous medium. Chemical tag a1 is attached to A1. After the organic solvent tert-butyl methyl ether is added, the reaction product of A1 + a1 enters the organic layer. Aldosterone and cortisol that have not reacted with chemical tag a1 also enter the organic layer. (Formula II1, aldosterone is added to chemical label b1) (Formula II 2, cortisol is added to chemical label b1) The above reaction occurs in an organic medium, during the process of attaching the chemical tag b1; 5) Eight chemically tagged compounds were analyzed using chromatography-mass spectrometry; Chromatographic conditions: Mobile phase A: Methanol Mobile phase B: 0.1% formic acid aqueous solution Gradient condition: Figure 2 The successful integration of typical chromatograms for chemical tags a1 and b1 demonstrates that simultaneous detection of compounds with significantly different properties has been achieved.

[0057] The linear regressions of eight typical compounds are as follows: Figures 6-13 .

[0058] 1) Norepinephrine, linear regression coefficient r = 0.9998; 2) The linear regression coefficient for adrenaline was r = 0.9995; 3) Norepinephrine, linear regression coefficient r = 0.9969; 4) 3-Methoxytyramine, linear regression coefficient r = 0.9996; 5) Dopamine, linear regression coefficient r = 0.9998; 6) Adrenaline, linear regression coefficient r = 0.9995; 7) Aldosterone, linear regression coefficient r = 0.9996; 8) Cortisol, linear regression coefficient r=0.9969.

[0059] Table 2. Results of content determination of 8 typical compounds .

[0060] Example 2 Using the same eight typical compounds—dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol—as examples, different chemical labels a1 were used as Example 2. In a single test of a single sample, the simultaneous analysis of the above compounds in 100-200 μL of biological sample was completed using only one pretreatment method.

[0061] Chemical label a1 Benzoyl chloride: Chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride: 1) Introduce chemical tag a1, benzoyl chloride: Take 200 μL of plasma and place it in a centrifuge tube. Add 20 μL of stable isotope internal standard solution, 100 μL of sodium carbonate buffer solution, and 10 μL of benzoyl chloride solution. Mix well at room temperature and let stand for 10 minutes. 2) In a test tube containing chemical label a1, add 1 ml of tert-butyl methyl ether, mix well, and separate the tert-butyl methyl ether layer; Different organic reagents were tried, including tert-butyl methyl ether, n-hexane, ethyl acetate, etc., but only tert-butyl methyl ether had the highest extraction efficiency; 3) Add chemical label b1: Add 5 μL of acetic acid and 10 μL of 1-(2-hydrazino-2-oxoethyl)pyridinium chloride, mix well, and let stand at room temperature for 10 minutes; 4) The solution after the reaction was dried under nitrogen at room temperature, redissolved with 25% methanol solution, and injected into a liquid chromatography-mass spectrometry (LC-MS) instrument for analysis; The reaction equations for the chemical labeling process described above are shown in equations III1-III6 and IV1-IV2: (Formula III1, dopamine is attached to chemical tag a1) (Formula III2, adrenaline is attached to chemical tag a1) (Formula III3, norepinephrine is attached to chemical tag a1) (Formula III4, with adrenaline linked to chemical tag a1) (Formula III5, norepinephrine is attached to chemical tag a1) (Formula III 6,3-methoxytyramine is added to chemical tag a1) The above reaction occurs in the aqueous layer. Chemical tag a1 is attached to A1. After the organic solvent tert-butyl methyl ether is added, the reaction product of A1 + a1 enters the organic layer. Aldosterone and cortisol, which have not reacted with chemical tag a1, also enter the organic layer. (Formula IV1, aldosterone is included in chemical label b1) (Formula IV2, cortisol is added to chemical tag b1) The above reaction occurs in an organic medium, and chemical tag b1 is connected; Figure 3 The successful integration of typical chromatograms for chemical tags a1 and b1 demonstrates that simultaneous detection of compounds with significantly different properties has been achieved.

[0062] Example 3 Taking the same eight typical compounds—dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, epinephrine, aldosterone, and cortisol—as examples, different chemical labels a1 and different operating methods were used. As Example 3, this method enabled the simultaneous analysis of the above compounds in 100-200 μL of biological samples using only one pretreatment method.

[0063] Chemical label a1 6-aminoquinolinyl-N-hydroxysuccinimide carbamate: Chemical label b1 1-(2-hydrazino-2-oxoethyl)pyridinium chloride: 1) Protein removal: Take 100 μL of plasma or series of standard solutions, add 20 μL of stable isotope internal standard solution, and add 600 μL of acetonitrile; a. Different organic reagents were tried, including acetonitrile, tert-butyl methyl ether, methanol, chloroform, dichloromethane, ethyl acetate, etc. Only acetonitrile had the highest extraction efficiency and was most suitable as a medium for the tandem connection of different chemical tags. b. Some organic solvents have low extraction efficiency; for example, tert-butyl methyl ether has an extraction efficiency of less than one-third that of acetonitrile. Because the solubility of the product varies depending on the chemical label in Example 3, tert-butyl methyl ether is unsuitable for this example, and acetonitrile is the most suitable organic extraction solvent. c. Some organic solvents are not suitable as media for the tandem connection of chemical tags. For example, methanol has too high a mutual solubility with water, which means that chemical tags cannot obtain the required medium environment when connected in series. 2) Chemical tag a1: Following the selection criteria for chemical tag a1, 6-aminoquinolinyl-N-hydroxysuccinimide carbamate was chosen as chemical tag a1. Add 50 μL of borate buffer and 50 μL of 6-aminoquinolinyl-N-hydroxysuccinimide carbamate, and mix well. 3) Separate the acetonitrile layer: Centrifuge, place the supernatant in a centrifuge tube containing inert salt to promote layering of the solution; separate the aqueous phase and organic phase; add chemical label b1: add 5 μL of acetic acid, add 10 μL of 1-(2-hydrazino-2-oxoethyl)pyridinium chloride, mix well, and let stand at room temperature for 10 minutes; 4) The final solution was dried, redissolved in 15% methanol aqueous solution, and injected into a liquid chromatography-mass spectrometer for analysis; The reaction equations for the chemical tag insertion that occur in the above process are shown in equations V1-V6 and VI1-VI2.

[0064] (Formula V1, dopamine is attached to chemical tag a1) (Formula V2, adrenaline is attached to chemical tag a1) (Formula V3, norepinephrine is attached to chemical tag a1) (Formula V4, modifying adrenaline to include chemical tag a1) (Formula V5, norepinephrine is attached to chemical tag a1) (Formula V6, 3-methoxytyramine is added to chemical tag a1) The above reaction occurs in the aqueous layer, where chemical tag a1 is introduced, and the reaction product A1+a1 continuously enters the organic layer; aldosterone and cortisol, which react with chemical tag a1, also enter the organic layer. (Formula VI1, aldosterone is added to chemical label b1) (Formula VI2, cortisol is added to chemical tag b1) The above reaction occurs in the organic layer, where chemical tag b1 is attached, and the reaction products remain in the organic layer.

[0065] Figure 4 The successful integration of typical chromatograms for chemical tags a1 and b1 demonstrates that simultaneous detection of compounds with significantly different properties has been achieved.

[0066] In summary, this invention provides a method for simultaneously detecting compounds with significantly different properties by continuously connecting different chemical tags in series within the same sample. The method includes first connecting a chemical tag a1 after simple processing of the biological sample; then, as needed, connecting chemical tags a2-an that react in an aqueous medium; allowing the target compounds with the chemical tags, as well as those not reacting with chemical tags a1-an, to enter the organic layer or solid-phase extraction layer through organic solvent extraction or solid-phase extraction; continuing to connect chemical tag b1, and so on, connecting several different chemical tags b2-bm that react in organic and solid-phase media. The chemical tag reagents do not react chemically with each other; each chemical tag reacts sequentially with its corresponding compound in series, partially altering the chemical properties of the target compound. This eliminates the need to divide a biological sample into several portions and process and measure them separately using different pretreatment methods. Instead, the same pretreatment method and detection system are used to achieve simultaneous detection, solving the problem of previously requiring compounds with significantly different properties to be divided into several portions and measured using different detection systems, greatly improving the speed and throughput of analysis and detection.

[0067] The specific embodiments of the present invention have been described above. It should be understood that the present invention is not limited to the specific embodiments described above, and those skilled in the art can make various modifications or variations within the scope of the claims, which do not affect the essence of the present invention.

Claims

1. A method for simultaneous detection of different types of compounds with significantly different properties in the same sample, characterized in that, The method does not require dividing the sample into multiple portions for separate sample pretreatment and analysis. Instead, it uses the same pretreatment method and the same analytical system for analysis on a single sample. The method includes the following steps: S1. After simple processing of the biological sample, the first chemical tag a1 is attached, so that the target compound of class A1 is attached to the chemical tag a1, generating a series of compounds A1+a1, where A1 is a class of target compounds that react with the chemical tag a1. S2. Using organic solvents or solid-phase extraction methods, the compound with chemical tag a1 and other target compounds B1 that have not reacted with chemical tag a1 are extracted from the aqueous phase and introduced into an organic or solid medium in preparation for the next stage of chemical tag introduction. Among them, the A1 type target compounds can enter the organic or solid-phase extraction medium by changing their solubility by introducing the corresponding chemical tag a1 in the aqueous medium. S3. In the solution obtained in step S2, chemical tag b1 is added so that target compound of type B1 is added to chemical tag b1, generating a series of compounds B1+b1; B1 is a type of target compound that reacts with chemical tag b1; different chemical tags do not react with each other; each chemical tag reagent has high reactivity only for the type of compound that reacts with it; S4. The final reaction solution can be directly analyzed by mass spectrometry or dried, reconstituted, and then analyzed by mass spectrometry. The target compounds for class A1 are dopamine, norepinephrine, epinephrine, 3-methoxytyrosine, norepinephrine, and norepinephrine; the target compounds for class B1 are aldosterone and cortisol.

2. The method according to claim 1, characterized in that, Biological samples are selected from plasma, serum, cerebrospinal fluid, tissue homogenate, dried blood spots, urine, hair, sweat, or saliva.

3. The method according to claim 1, characterized in that, Chemical label reagent a1 is propionic anhydride, and chemical label reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride.

4. The method according to claim 1, characterized in that, Chemical label reagent a1 is benzoyl chloride, and chemical label reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride.

5. The method according to claim 1, characterized in that, Chemical label reagent a1 is 6-aminoquinolino-N-hydroxysuccinimide carbamate, and chemical label reagent b1 is 1-(2-hydrazino-2-oxoethyl)pyridinium chloride.

6. The method according to claim 1, characterized in that, Various compounds are connected to different chemical tags through a series continuous connection method.

7. The method according to claim 1, characterized in that, Each chemically labeled reagent has a highly ionizing center.

8. The method according to claim 1, characterized in that, Each tagged target compound is soluble in the sample dissolution solvent used before final liquid chromatography-mass spectrometry (LC-MS) injection.

Citation Information

Patent Citations

  • Methods and kits for the derivatization of a biogenic amine

    CN109661581A

  • Metabolic markers and kits for detecting affective disorders and methods of use

    CN112630311A

  • Method and kit for detecting catecholamine and metabolite in blood plasma

    CN112730699A

  • Multiplexing derivatized anayltes using mass spectroscopy

    US20110301063A1